Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06295809 |
|---|---|
| Brief Title: | A Study of (Neo)Adjuvant V940 and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007) |
| First Submitted : | February 29, 2024 |
| First Submitted that Met QC Criteria : | February 29, 2024 |
| First Posted : | March 6, 2024 |
| Last Update Submitted that Met QC Criteria : | May 10, 2024 |
| Last Update Posted : | May 13, 2024 |